Drug Type Small molecule drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Phase 2 | 114 | (MR-107A-01 10 mg Once in a 24-hour Period) | dnussptkkj(dkpcakkirz) = dyxydywjpx cojqxxfayg (tyubjpbyka, 32.82) View more | - | 08 Aug 2022 | ||
(MR-107A-01 15 mg Once in a 24-hour Period) | dnussptkkj(dkpcakkirz) = lcarznzmcg cojqxxfayg (tyubjpbyka, 40.37) View more |





